Emkay Global Financial Services Limited (BOM:532737)
India · Delayed Price · Currency is INR 235.00
-3.40 (-1.43%)
At close: Aug 1, 2025
Sage Therapeutics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Interest and Dividend Income | 171.13 | 132.71 | 102.99 | 83.19 | 81.72 | Upgrade |
Total Interest Expense | 46.19 | 34.52 | 23.39 | 15.89 | 16.04 | Upgrade |
Net Interest Income | 124.93 | 98.18 | 79.6 | 67.3 | 65.68 | Upgrade |
Brokerage Commission | 3,126 | 2,467 | 1,693 | 1,689 | 1,349 | Upgrade |
Gain on Sale of Investments (Rev) | 19.66 | 129.61 | 193.88 | 87.58 | 143.44 | Upgrade |
Other Revenue | 265.81 | 400.57 | 142.61 | 851.37 | 33.73 | Upgrade |
Revenue Before Loan Losses | 3,536 | 3,096 | 2,109 | 2,696 | 1,592 | Upgrade |
Provision for Loan Losses | -1.44 | -0.41 | 0.15 | 0.66 | 0.13 | Upgrade |
| 3,538 | 3,096 | 2,109 | 2,695 | 1,592 | Upgrade | |
Revenue Growth (YoY) | 14.26% | 46.81% | -21.74% | 69.28% | 24.62% | Upgrade |
Salaries & Employee Benefits | 1,709 | 1,508 | 1,151 | 1,091 | 869.25 | Upgrade |
Cost of Services Provided | 391.27 | 408.03 | 339.63 | 288.21 | 226.08 | Upgrade |
Other Operating Expenses | 706.7 | 651.43 | 396.04 | 778.51 | 245.03 | Upgrade |
Total Operating Expenses | 2,923 | 2,666 | 1,979 | 2,234 | 1,418 | Upgrade |
Operating Income | 615.05 | 429.81 | 129.75 | 460.4 | 173.73 | Upgrade |
Currency Exchange Gains | -7.83 | -5.57 | -5.24 | 1.52 | -0.13 | Upgrade |
EBT Excluding Unusual Items | 606.38 | 426.82 | 125.79 | 451.35 | 166.62 | Upgrade |
Other Unusual Items | -0.01 | -0.3 | -0 | -0.28 | 0.04 | Upgrade |
Pretax Income | 606.47 | 426.73 | 126.73 | 450.58 | 166.72 | Upgrade |
Income Tax Expense | 38.16 | 117.87 | -14.59 | 112.2 | 55.33 | Upgrade |
Earnings From Continuing Ops. | 568.31 | 308.86 | 141.33 | 338.37 | 111.39 | Upgrade |
Earnings From Discontinued Ops. | - | 15.52 | -0.56 | -0.34 | -0.06 | Upgrade |
Net Income | 568.31 | 324.39 | 140.76 | 338.04 | 111.33 | Upgrade |
Net Income to Common | 568.31 | 324.39 | 140.76 | 338.04 | 111.33 | Upgrade |
Net Income Growth | 75.19% | 130.45% | -58.36% | 203.64% | - | Upgrade |
Shares Outstanding (Basic) | 25 | 25 | 25 | 25 | 25 | Upgrade |
Shares Outstanding (Diluted) | 26 | 25 | 25 | 26 | 25 | Upgrade |
Shares Change (YoY) | 1.69% | 2.79% | -4.95% | 5.73% | 0.13% | Upgrade |
EPS (Basic) | 22.80 | 13.16 | 5.71 | 13.72 | 4.52 | Upgrade |
EPS (Diluted) | 21.95 | 12.74 | 5.69 | 12.97 | 4.52 | Upgrade |
EPS Growth | 72.30% | 124.00% | -56.14% | 187.03% | - | Upgrade |
Free Cash Flow | -89.52 | 153.99 | -712.47 | 549.34 | -469.55 | Upgrade |
Free Cash Flow Per Share | -3.46 | 6.05 | -28.76 | 21.08 | -19.05 | Upgrade |
Dividend Per Share | 1.500 | 1.500 | 1.000 | 1.250 | 1.000 | Upgrade |
Dividend Growth | - | 50.00% | -20.00% | 25.00% | - | Upgrade |
Operating Margin | 17.39% | 13.88% | 6.15% | 17.08% | 10.91% | Upgrade |
Profit Margin | 16.06% | 10.48% | 6.67% | 12.54% | 6.99% | Upgrade |
Free Cash Flow Margin | -2.53% | 4.97% | -33.78% | 20.39% | -29.50% | Upgrade |
Effective Tax Rate | 6.29% | 27.62% | - | 24.90% | 33.19% | Upgrade |
Revenue as Reported | 3,612 | 3,150 | 2,155 | 2,738 | 1,618 | Upgrade |
Source: S&P Global Market Intelligence. Capital Markets template. Financial Sources.